课题基金 / 基金详情

Regulation of IFN-gamma production in human tuberculosis

Regulation of IFN-gamma production in human tuberculosis
人类结核病中 IFN-γ 产生的调节
批准号:
7369790
负责人:
Peter F. Barnes
金额:
$25.58万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2010-02-28

项目摘要

项目成果

Peter F. Barnes的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):干扰素(IFN)- γ对抵抗结核分枝杆菌和其他细胞内病原体的免疫至关重要。免疫无效的结核病患者对分枝杆菌抗原的反应产生ifn - γ mRNA和蛋白的减少,但这些异常的机制尚不清楚。我们的初步数据表明,cAMP反应元件结合蛋白/激活转录因子/激活蛋白-1 (CREB/ATF/AP-1)家族的转录因子通过与ifn - γ近端启动子结合来调节IFNgamma的产生。我们的目标是了解CREB/ATF/AP-1转录因子在结核分枝杆菌应答中调节ifn - γ产生的机制。我们的具体目标是:1。利用微亲和纯化和染色质免疫沉淀技术,鉴定体内对结核分枝杆菌有应答的CD4+和CD8+ t细胞中与ifn - γ近端启动子结合的转录因子;2. 通过细胞内抗体传递和sirna转录因子,评估CREB/ATF/AP-1等转录因子中和对M. tuberculosis诱导的CD4+和CD8+ t细胞ifn - γ基因表达的影响;3. 表征结合CD4+和CD8+细胞ifn - γ近端启动子的转录复合物(增强体)的动力学和蛋白-蛋白相互作用,使用共免疫沉淀和染色质免疫沉淀,然后进行Western blotting。4. 了解结核病患者CREB/ATF/AP-1转录因子异常表达的介导机制。转录因子水平将确定结核患者治疗期间PBMC t细胞亚群。我们将确定暴露于免疫抑制细胞因子或结核分枝杆菌感染的巨噬细胞是否影响CREB/ATF/AP-1的表达。结核患者t细胞中的CREB/ATF/AP-1水平将通过病毒表达载体和核感染增强,并将确定对ifn - γ产生的影响。
英文摘要
DESCRIPTION (provided by applicant): Interferon (IFN)-gamma is central to immunity against Mycobacterium tuberculosis and other intracellular pathogens. Tuberculosis patients with ineffective immunity produce reduced amounts of IFN-gamma mRNA and protein in response to mycobacterial antigens, but the mechanisms underlying these abnormalities are unknown. Our preliminary data indicate that transcription factors of the cAMP response element-binding protein/activation transcription factor/activator protein-1 (CREB/ATF/AP-1) family regulate production of IFNgamma by binding to the IFN-gamma proximal promoter. Our goal is to understand the mechanisms by which CREB/ATF/AP-1 transcription factors regulate IFN-gamma production in response to M. tuberculosis. Our specific aims are: 1. Identify transcription factors that bind to the IFN-gamma proximal promoter in vivo in CD4+ and CD8+ T-cells that respond to M. tuberculosis, using microaffinity purification and chromatin immunoprecipitation; 2. Evaluate the effects of neutralization of CREB/ATF/AP-1 and other transcription factors on M. tuberculosis-induced IFN-gamma gene expression by CD4+ and CD8+ T-cells, using intracellular antibody delivery and siRNAs to transcription factors; 3. Characterize the kinetics and protein-protein interactions of the transcriptional complex (enhanceosome) that binds to the IFN-gamma proximal promoter of CD4+ and CD8+ cells, using coimmunoprecipitation and chromatin immunoprecipitation, followed by Western blotting. 4. Understand the mechanisms that mediate aberrant expression of CREB/ATF/AP-1 transcription factors in tuberculosis patients. Transcription factor levels will be determined in PBMC T-cell subpopulations in tuberculosis patients during treatment. We will determine if exposure to immunosuppressive cytokines or to M. tuberculosis-infected macrophages affects CREB/ATF/AP-1 expression. CREB/ATF/AP-1 levels in T-cells of tuberculosis patients will be enhanced by viral expression vectors and nucleofection, and the effects on IFN-gamma production will be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NK cells and IL-15 in the human innate immune response to tuberculosis
NK cells and IL-15 in the human innate immune response to tuberculosis
Regulation of IFN-gamma production in human tuberculosis
Regulation of IFN-gamma production in human tuberculosis
海外基金